International Symposium on Pertussis Vaccine TrialsBROWN, Fred; GRECO, Donato; MASTRANTONIO, Paola et al.Developments in biological standardization. 1997, Num 89, issn 0301-5149, 423 p.Conference Proceedings

Case definitionsSALMASO, S; MOIRAGHI, A; BARALE, A et al.Developments in biological standardization. 1997, Num 89, pp 135-142, issn 0301-5149Conference Paper

Methods for estimating serological correlates of protectionSIBER, G. R.Developments in biological standardization. 1997, Num 89, pp 283-296, issn 0301-5149Conference Paper

European union research strategies on vaccinesHANSEN, B.Developments in biological standardization. 1997, Num 89, pp 29-36, issn 0301-5149Conference Paper

Regulatory issues concerning pertussis vaccinesTIRU, M.Developments in biological standardization. 1997, Num 89, issn 0301-5149, p.341Conference Paper

Regulatory and standardization issuesWINSNES, R.Developments in biological standardization. 1997, Num 89, pp 349-350, issn 0301-5149Conference Paper

Bordetella parapertussis infectionsMASTRANTONIO, P; GIULIANO, M; STEFANELLI, P et al.Developments in biological standardization. 1997, Num 89, pp 255-259, issn 0301-5149Conference Paper

Diagnostic polymerase chain reactionREIZENSTEIN, E.Developments in biological standardization. 1997, Num 89, pp 247-254, issn 0301-5149Conference Paper

Isolation, identification and characterization of Bordetella pertussisGUISO, N.Developments in biological standardization. 1997, Num 89, pp 233-238, issn 0301-5149Conference Paper

Pertussis : A worldwide problemIVANOFF, B; ROBERTSON, S. E.Developments in biological standardization. 1997, Num 89, pp 3-13, issn 0301-5149Conference Paper

Public health implications : United KingdomMILLER, E.Developments in biological standardization. 1997, Num 89, pp 367-368, issn 0301-5149Conference Paper

Epidemiological determinants of pertussisMILLER, E; GAY, N. J.Developments in biological standardization. 1997, Num 89, pp 15-23, issn 0301-5149Conference Paper

Serological responses to infection with B. pertussisGIAMMANCO, A; TAORMINA, S; GENOVESE, M et al.Developments in biological standardization. 1997, Num 89, pp 213-220, issn 0301-5149Conference Paper

Preparation and composition of acellular pertussis vaccines. Consideration of potential effects on vaccine efficacyHEWLETT, E. L.Developments in biological standardization. 1997, Num 89, pp 143-151, issn 0301-5149Conference Paper

A comparison of enzyme immuno-assays used to measure serum antibodies to components of Bordetella pertussisLYNN, F; REED, G. F; MEADE, B. D et al.Developments in biological standardization. 1997, Num 89, pp 197-204, issn 0301-5149Conference Paper

Common side effects in the Italian and Stockholm I trialsTOZZI, A. E; OLIN, P.Developments in biological standardization. 1997, Num 89, pp 105-108, issn 0301-5149Conference Paper

Comparison of serological results in the NIAID multicenter acellular pertussis trial with recent efficacy trialsEDWARDS, K. M; DECKER, M. D.Developments in biological standardization. 1997, Num 89, pp 265-273, issn 0301-5149Conference Paper

Implications of different study designs for the evaluation of acellular pertussis vaccinesFINE, P. E. M.Developments in biological standardization. 1997, Num 89, pp 123-133, issn 0301-5149Conference Paper

Issues regarding future research on pertussis vaccinesBURNS, D.Developments in biological standardization. 1997, Num 89, issn 0301-5149, p.377Conference Paper

Some thoughts for future pertussis research in EuropePLETSCHETTE, M.Developments in biological standardization. 1997, Num 89, issn 0301-5149, p.391Conference Paper

A consideration of control requirements for acellular pertussis vaccinesCORBEL, M. J; XING, D. K. L.Developments in biological standardization. 1997, Num 89, pp 343-347, issn 0301-5149Conference Paper

Absolute efficacy of acellular pertussis vaccines in household settingsSTORSAETER, J; GUSTAFSSON, L.Developments in biological standardization. 1997, Num 89, pp 153-158, issn 0301-5149Conference Paper

Factors influencing the analysis of secondary prevention of pertussisWIRSING VON KÖNIG, C. H; SCHMITT, H. J; BOGAERTS, H et al.Developments in biological standardization. 1997, Num 89, pp 175-179, issn 0301-5149Conference Paper

The effectiveness of whole-cell pertussis vaccinesPLOTKIN, S. A.Developments in biological standardization. 1997, Num 89, pp 171-174, issn 0301-5149Conference Paper

Absolute and relative efficacy of whole-cell vaccinesJAFARI, H. S.Developments in biological standardization. 1997, Num 89, pp 167-170, issn 0301-5149Conference Paper